BBVA
ALXN

Banco Bilbao Vizcaya Argentaria’s Alexion Pharmaceuticals ALXN Stock Holding History

Banco Bilbao Vizcaya Argentaria’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-30,320
Closed -$5.49M – 811
2021
Q2 		$5.49M Buy
30,320
+1,838
+6% +$316K 0.1% 189
2021
Q1 		$4.34M Buy
28,482
+2,855
+11% +$442K 0.09% 211
2020
Q4 		$4M Buy
25,627
+9,008
+54% +$1.16M 0.09% 196
2020
Q3 		$1.9M Buy
16,619
+2,510
+18% +$271K 0.06% 274
2020
Q2 		$1.58M Sell
14,109
-82
-0.6% -$8.71K 0.05% 284
2020
Q1 		$1.27M Sell
14,191
-8,170
-37% -$802K 0.05% 320
2019
Q4 		$2.42M Buy
+22,361
New +$2.39M 0.08% 276

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.96B AUM 48.96% 1-Year Est. Return

Banco Bilbao Vizcaya Argentaria's ALXN Position: Q3 2021 in Review

Banco Bilbao Vizcaya Argentaria sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 30,320 shares — an estimated $5.49M sold.

Banco Bilbao Vizcaya Argentaria first reported a position in ALXN in Q4 2019 and held it in 7 quarters. The position peaked at $5.49M in Q2 2021. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • Banco Bilbao Vizcaya Argentaria reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Banco Bilbao Vizcaya Argentaria sold 30,320 Alexion Pharmaceuticals shares in Q3 2021, an estimated $5.49M.
  • Banco Bilbao Vizcaya Argentaria first reported a position in Alexion Pharmaceuticals in Q4 2019 and held it in 7 quarters.
  • Banco Bilbao Vizcaya Argentaria's Alexion Pharmaceuticals position peaked at $5.49M in Q2 2021.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Banco Bilbao Vizcaya Argentaria's 13F filing for Q3 2021, filed 12 Nov 2021.